Cardiac troponins are one of the cardiac biomarkers or diagnostic markers centralized to myocardial infarction or heart muscle cell death diagnosis.
Troponin is found in skeletal muscle and cardiac muscle of human body, thus increased level of the cardiac troponin circulating in the blood represents the susceptibility of myocardial infarction.
In 2019, the market size of Cardiac Troponin is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Cardiac Troponin.
This report studies the global market size of Cardiac Troponin, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Cardiac Troponin sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Abbott Diagnostics
Roche
bioMrieux
BG Medicine
Ortho Clinical Diagnostics
Singulex
Alere
Siemens Healthcare Diagnostics
Beckman Coulter
LifeSign
Market Segment by Product Type
Laboratory Testing
Point-of-care Testing
Market Segment by Application
Acute Coronary Syndrome
Myocardial Infarction
Congestive Heart Failure
Others Applications
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)